TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating ...
Medical Health News,
TYME Presented Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends…
TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
Erie News Now,
TYME Presented Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends…
TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
TMCnet.com,
TYME Presented Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends…
TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
NASDAQ,
TYME Presented Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends…
TYME Provides Business Update and Reports Fourth Quarter …
TMCnet.com,
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results TYME-88-Panc…
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
Morning Star,
TYME-88-Panc Continues to Show Encouraging Survival Trend with Additional Data to Be Presented in Third Quarter 2019 Single…
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
Yahoo! Finance USA,
TYME-88-Panc Continues to Show Encouraging Survival Trend with Additional Data to Be Presented in Third Quarter 2019Single…
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
Benzinga,
TYME-88-Panc Continues to Show Encouraging Survival Trend with Additional Data to Be Presented in Third Quarter 2019 Single…
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
NASDAQ,
TYME-88-Panc Continues to Show Encouraging Survival Trend with Additional Data to Be Presented in Third Quarter 2019 Single…
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
USA Life Sciences Database,
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM …
TYME's SM-88 First Human Study in …
TMCnet.com,
TYME's SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs New oral…
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
Morning Star,
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM …
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
NASDAQ,
TYME's SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs New oral…
TYMEs SM88 First Human Study in Patients with Metastatic Cancer Published in the Journal Investigational New Drugs
Bioportfolio,
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM …